Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Portal Vein vs Cell pouch
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(160)
•••
Post by Redbaron2211on Feb 25, 2022 2:43pm
316 Views
Post# 34462596

Portal Vein vs Cell pouch

Portal Vein vs Cell pouchChart comparing what Vertex is currently doing with a portal vein injection and Sernova's Cell pouch.

User image

Clearly its a matter of buying out Sernova for Vertex or any other big pharma with iPSC to corner the market.

"In multiple collaborations with global pharmaceutical partners, we have demonstrated long-term insulin independence using advanced stem cell-derived diabetes technologies in the Cell Pouch in accepted animal models of type 1 diabetes (T1D). This work supports the concept that the Cell Pouch, in combination with an advanced stem cell source designed to provide an unlimited supply of therapeutic cells, could provide a solution for millions of people with T1D."
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities